Zacks Research Issues Negative Outlook for TriMas Earnings

TriMas Co. (NASDAQ:TRS) – Analysts at Zacks Research reduced their Q1 2025 earnings estimates for shares of TriMas in a research report issued to clients and investors on Monday, March 10th. Zacks Research analyst M. Das now anticipates that the industrial products company will post earnings of $0.43 per share for the quarter, down from their previous estimate of $0.44. The consensus estimate for TriMas’ current full-year earnings is $1.69 per share. Zacks Research also issued estimates for TriMas’ Q1 2026 earnings at $0.47 EPS and FY2027 earnings at $2.18 EPS.

TRS has been the topic of several other reports. StockNews.com upgraded shares of TriMas from a “sell” rating to a “hold” rating in a report on Wednesday, November 13th. BWS Financial reiterated a “buy” rating and set a $40.00 price target on shares of TriMas in a research note on Friday, February 28th.

TriMas Stock Down 0.7 %

Shares of TRS opened at $23.98 on Wednesday. The firm has a market cap of $973.18 million, a P/E ratio of 37.47 and a beta of 0.65. TriMas has a 12-month low of $19.33 and a 12-month high of $28.51. The company’s 50-day moving average price is $23.56 and its 200 day moving average price is $25.07. The company has a current ratio of 2.83, a quick ratio of 1.44 and a debt-to-equity ratio of 0.60.

TriMas Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 28th were paid a dividend of $0.04 per share. The ex-dividend date was Friday, February 28th. This represents a $0.16 dividend on an annualized basis and a yield of 0.67%. TriMas’s dividend payout ratio (DPR) is presently 27.12%.

Insiders Place Their Bets

In related news, Director Shawn Sedaghat acquired 554,149 shares of the stock in a transaction dated Monday, March 10th. The stock was acquired at an average cost of $24.07 per share, with a total value of $13,338,366.43. Following the completion of the transaction, the director now owns 900,974 shares in the company, valued at $21,686,444.18. This represents a 159.78 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Jeffrey A. Fielkow acquired 2,500 shares of the stock in a transaction dated Friday, February 28th. The shares were bought at an average cost of $20.78 per share, with a total value of $51,950.00. Following the completion of the transaction, the director now owns 11,013 shares of the company’s stock, valued at approximately $228,850.14. This represents a 29.37 % increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 806,246 shares of company stock worth $19,338,213 over the last three months. Company insiders own 1.10% of the company’s stock.

Hedge Funds Weigh In On TriMas

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. FMR LLC boosted its holdings in TriMas by 1.7% in the third quarter. FMR LLC now owns 44,082 shares of the industrial products company’s stock valued at $1,125,000 after purchasing an additional 729 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in TriMas by 3.7% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 23,106 shares of the industrial products company’s stock valued at $568,000 after purchasing an additional 834 shares in the last quarter. Sterling Capital Management LLC boosted its holdings in TriMas by 815.5% in the fourth quarter. Sterling Capital Management LLC now owns 1,300 shares of the industrial products company’s stock valued at $32,000 after purchasing an additional 1,158 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in TriMas by 3.3% in the third quarter. JPMorgan Chase & Co. now owns 38,461 shares of the industrial products company’s stock valued at $982,000 after purchasing an additional 1,227 shares in the last quarter. Finally, MetLife Investment Management LLC boosted its holdings in TriMas by 5.9% in the fourth quarter. MetLife Investment Management LLC now owns 24,788 shares of the industrial products company’s stock valued at $610,000 after purchasing an additional 1,378 shares in the last quarter. 99.42% of the stock is owned by institutional investors and hedge funds.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.